Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol
Guardado en:
Autores principales: | Valentina Lorenzoni, Isotta Triulzi, Giuseppe Turchetti, Marzia Del Re, Romano Danesi, Valentina Orlando, Sara Mucherino, Enrica Menditto, Annalisa Capuano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12f125686b9448c88c010d27e172220b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug-utilisation profiles and COVID-19
por: Valentina Orlando, et al.
Publicado: (2021) -
Optimising sampling and analysis protocols in environmental DNA studies
por: Andrew Buxton, et al.
Publicado: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021) -
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity
por: Kwoneel Kim, et al.
Publicado: (2020) -
Particle platforms for cancer immunotherapy
por: Serda RE
Publicado: (2013)